Yahoo Finance

Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia

Study Results are Intended to Support PMA Approval of Adagio’s vCLAS TM Cryoablation System Designed to Address the Large Population of Patients with Ventricular Arrhythmias LAGUNA HILLS, Calif., ...
Morningstar

Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium

97% Acute Effectiveness and Favorable Safety Results from Proprietary ULTC for Ventricular Tachycardia Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in ...
Yahoo Finance

Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities

LAGUNA HILLS, Calif., October 15, 2025--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or the "Company"), a leading innovator in catheter ablation technologies for the ...
FierceBiotech

Cryoablation developer Adagio Medical lays off staff, refocuses on US study

Cryoablation devicemaker Adagio Medical has opted to pause the European launch of one of its catheters, currently in the early stages, and will instead focus efforts on obtaining approval in the U.S.
Benzinga.com

Why Adagio Medical Holdings (ADGM) Stock Is Skyrocketing

Adagio Medical Holdings Inc (NASDAQ:ADGM) shares are trading higher by 124% to $2.07 during Thursday’s session after the FDA granted Breakthrough Device Designation for the vCLAS cryoablation system.